Navigation Links
PharmAthene Reports Third Quarter 2010 Financial and Operational Results
Date:11/11/2010

ANNAPOLIS, Md., Nov. 11, 2010 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter and nine months ended September 30, 2010.

For the third quarter of 2010, PharmAthene recognized revenues of $6.2 million compared to $6.8 million in the same period of 2009.  For the nine months ended September 30, 2010 and 2009, respectively, PharmAthene recognized revenues of $14.1 million and $20.4 million.  Revenues for the most recent quarter and nine months ended September 30, 2010 consisted primarily of contract funding from the U.S. government for the development of SparVax™, Valortim®, and  Protexia®.

The decline in revenue in the third quarter and first nine months of 2010 compared to 2009 is attributable to (i) the completion of activities under the Company's existing Department of Defense (DoD) contract for Protexia®, which concluded in the third quarter of 2009, partially offset by modest funding from the DoD for this program in the second and third quarters of 2010, and (ii) reduced activity in the Company's Valortim® program, (iii) the completion of all activities in the Company's plague program during early 2010, (iv) partially offset by increased revenues under the Company's SparVax™ program.

Research and development expenses were $6.2 million and $7.9 million for the quarter ended September 30, 2010 and 2009, respectively.  Research and development expenses were $17.1 million and $23.9 million for the nine months ended September 30, 2010 and 2009, respectively.  

Research and development expenses decreased in the third quarter and first nine months of 2010 compared to the prior year period as a result of decreased activity in
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
2. PharmAthene Announces Pricing of $15 Million Public Offering
3. PharmAthene Announces Proposed Common Stock Offering
4. PharmAthene Announces $3.9 Million Registered Direct Offering
5. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
6. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
7. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
8. PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
9. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
10. PharmAthene to Present at the 2010 Roth Capital Markets Growth Stock Conference on Monday, March 15, 2010
11. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Emerson Resources Inc. , a premier ... the Company’s Chief Executive Officer and Chairman of the ... of service. As part of Emerson Resources’ planned leadership ... named as Dr. Signorino’s successor. , Dr. Signorino ... made a significant contribution to the field during his ...
(Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
(Date:5/20/2013)... May 21, 2013 Grace Century ... in “game-changing” life science and health related private equity ... to its International Project Team. Dergham's expertise in finance ... multi-cultural depth to Grace Century as it continues to ... , Ms. Dergham holds both an under graduate degree ...
Breaking Biology Technology:Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
... N.Y., April 9 Is the United ... to study in a post-9/11 America? What,are ... international talent for,American biotechnology research and industrial ... in the department of biomedical,engineering at Boston ...
... acquire common stock held by American Red Cross, in ... ProMetic,s stake in PRDT to 77%, - American Red ... of PRDT, MONTREAL and CAMBRIDGE, England, April 9 ... ProMetic,has signed a Letter of Intent ("LOI") to acquire ...
... Inc. (TSX:,ARI), a biotechnology company discovering and developing the next wave ... Where: St. Andrew,s Club & Conference Centre, S7 ... 150 King Street West, 27th Floor, Toronto, Ontario, When: ... Webcast: ARIUS Research Inc.,s Annual and Special Meeting will be webcast ...
Cached Biology Technology:ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 7ARIUS 2008 Annual and Special Meeting of Shareholders 2
(Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
(Date:5/21/2013)... CAMBRIDGE, MA -- Over the past few decades, scientists ... including angioplasty balloons and metallic stents. While generally effective, ... of side effects. , A new study from MIT ... combines the benefits of angioplasty balloons and drug-releasing stents, ... a balloon is inflated in the artery for only ...
(Date:5/21/2013)... Australian scientists have charted the path of insulin action ... provides a comprehensive blueprint for understanding what goes wrong ... Sean Humphrey and Professor David James from Sydney,s Garvan ... early online edition of the prestigious journal Cell ... hormone plays a very important role in the body ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... of Illinois at Chicago have identified a novel function for ... in acute respiratory distress syndrome, also known as ARDS. ... and treatment of lung inflammation and injury. The research will ... this year and online June 29. ARDS is an ...
... exacerbate drought events throughout the world, resulting in large-scale ... addition, periods of drought vary from year to year ... to adapt to more severe conditions. Many modern ... However, evolution and cultivation in the cold, dry Andean ...
... gardens, we watch them turn gradually from hard, green ... This familiar and seemingly commonplace transformation masks a seething ... complex manner. For generations, agriculturalists and scientists have ... nutrient composition, more or less, one trait at a ...
Cached Biology News:UIC researchers make promising finding in severe lung disease 2Drought tolerance in potatoes 2Drought tolerance in potatoes 3The 21st century tomato 2The 21st century tomato 3
... salt solution. It is routinely used as an ... blood at refrigerator temperatures for approximately 10 weeks.1 ... collected into a container of this product and ... in a refrigerator at 2-8 C for 2 ...
... OligoMix or individual RNA sequences from high throughput ... small RNAs from LC Sciences. These products provide ... millions) of DESIGNED sequences delivered in a microtube ... containing a single verified RNA sequence. This is ...
... Chromatograph/Mass Spectrometer, utilizing many of the ... offers high throughput and excellent productivity, ... ratio. Like the GCMS-QP2010 Plus, the ... for optimum separation, 20 temperature ramps, ...
... Assay Kit contains all reagents necessary to ... lineage, as determined by staining for mineralization. ... necessary reagents and a protocol for quantifying ... product is useful for studying the effects ...
Biology Products: